文献速递创伤与烧伤重症综合管理与镇静镇痛

老年与非老年创伤患者中直接口服抗凝药与维生素K拮抗剂对结局的比较

Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在配对的抗凝创伤患者队列中,65岁及以上患者使用DOAC与院内死亡率降低相关,但该结论来自单中心回顾性研究。

该研究回顾了2011年1月至2018年7月单家一级创伤中心收治的创伤患者,筛选出服用DOAC或VKA者,按1:1倾向评分匹配后比较两组结局。匹配后DOAC组与VKA组各334例;65岁以下患者两组死亡率无显著差异(4.8% vs 1.6%,OR 3.0,95%CI 0.31-28.8,p=0.31),65岁以上患者DOAC组死亡率低于VKA组(3.0% vs 6.6%,OR 0.41,95%CI 0.17-0.99,p=0.048)。两组出院去向相似,DOAC组新鲜冰冻血浆使用较少(p=0.032),红细胞与凝血酶原复合物使用无显著差异。作者认为在65岁及以上接受抗凝治疗的创伤患者中,DOAC与院内死亡率降低及新鲜冰冻血浆使用减少相关。

要点

  • 65岁以上创伤患者中,DOAC组院内死亡率3.0% vs VKA组6.6%(OR 0.41,95%CI 0.17-0.99,p=0.048)。
  • 65岁以下创伤患者中,DOAC组与VKA组院内死亡率无显著差异(4.8% vs 1.6%,OR 3.0,95%CI 0.31-28.8,p=0.31)。
  • 匹配后两组出院至护理机构/康复机构比例(50.0% vs 50.6%,OR 0.98,95%CI 0.72-1.32,p=0.88)及出院回家比例(40.4% vs 38.6%,OR 1.08,95%CI 0.79-1.47,p=0.64)相似。
  • DOAC组新鲜冰冻血浆输注量少于VKA组(p=0.032),红细胞(p=0.86)与凝血酶原复合物(p=0.48)使用无显著差异。
  • 该研究为单家一级创伤中心的回顾性配对队列,证据等级为预后/流行病学 level III。

适用人群与场景

  • 2011年1月至2018年7月在大学医学中心长老会医院(一级创伤中心)就诊的创伤患者,且正在服用DOAC或VKA。

研究设计与关键结果

  • 研究类型为回顾性配对队列,共筛选32272例创伤患者,其中530例服用DOAC、1702例服用VKA;按1:1倾向评分匹配(基于患者特征、抗血小板药物使用、合并症和实验室值)后DOAC组334例 vs VKA组334例。
  • 主要终点院内死亡率:65岁以下患者DOAC组4.8% vs VKA组1.6%(OR 3.0,95%CI 0.31-28.8,p=0.31);65岁以上患者DOAC组3.0% vs VKA组6.6%(OR 0.41,95%CI 0.17-0.99,p=0.048)。
  • 出院至护理机构/康复机构比例DOAC组50.0% vs VKA组50.6%(OR 0.98,95%CI 0.72-1.32,p=0.88);出院回家比例DOAC组40.4% vs VKA组38.6%(OR 1.08,95%CI 0.79-1.47,p=0.64)。
  • DOAC组新鲜冰冻血浆输注量少于VKA组(p=0.032),红细胞(p=0.86)和凝血酶原复合物(p=0.48)使用无显著差异。

证据类型、等级与局限

  • 证据类型为单中心回顾性配对队列研究,原文给出的证据等级为预后/流行病学 level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在65岁及以上正在接受抗凝治疗的创伤患者中,使用DOAC与院内死亡率降低及新鲜冰冻血浆使用减少相关;该结论来自单中心回顾性配对队列,作者在结论中如此表述。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Direct oral anticoagulants (DOACs) are widely used among patients requiring anticoagulant therapy. These drugs are associated with a lower risk of bleeding than vitamin K antagonists (VKAs). However, the outcomes of elderly trauma patients receiving DOACs are not well known.

METHODS: We reviewed data from trauma patients at our level I trauma center (University of Pittsburgh Medical Center, Presbyterian Hospital) seen from January 2011 to July 2018. We identified trauma patients taking DOACs or VKAs and compared these cohorts using 1:1 propensity score-matching based on patient characteristics, antiplatelet use, comorbidities, and laboratory values. The primary outcome was in-hospital mortality. Secondary outcomes included the proportion of patients discharged to skilled nursing facility/rehabilitation facility discharge or to home, and transfusion volume.

RESULTS: Of 32,272 trauma patients screened, 530 were taking DOACs and 1,702 were taking VKAs. We matched 668 patients in a 1:1 ratio (DOACs group, 334 vs. VKAs group, 334). The DOACs group had similar mortality (4.8% vs. 1.6%; odds ratio (OR), 3.0; 95% confidence interval (CI), 0.31-28.8; p = 0.31) among patients younger than 65 years, but mortality differed (3.0% vs. 6.6%; OR, 0.41; 95% CI, 0.17-0.99; p = 0.048) among patients older than 65 years. The proportion of patients discharged to skilled nursing facility/rehabilitation facility (50.0% vs. 50.6%; OR, 0.98; 95% CI, 0.72-1.32; p = 0.88) and to home (40.4% vs. 38.6%; OR, 1.08; 95% CI, 0.79-1.47; p = 0.64) were similar. Patients in the DOACs group received fewer fresh frozen plasma (p = 0.032), but packed red blood cells (p = 0.86) and prothrombin complex concentrate (p = 0.48) were similar.

CONCLUSION: In this matched cohort of anticoagulated trauma patients, DOACs were associated with the decreased in-hospital mortality and decreased administration of fresh frozen plasma compared with VKAs among trauma patients 65 years or older taking anticoagulant therapy.

LEVEL OF EVIDENCE: Prognostic/Epidemiological, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Nishimura T, Guyette FX, Naito H, et al. Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients. J Trauma Acute Care Surg. 2020. PMID: 32544105. doi:10.1097/TA.0000000000002823

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。